| CGBIX | RBFFX | CGBIX / RBFFX | |
| Total Expense Ratio | 0.48 | 0.28 | 171% |
| Annual Report Gross Expense Ratio | 0.53 | 0.28 | 189% |
| Fund Existence | 13 years | 24 years | - |
| Gain YTD | 0.081 | -0.570 | -14% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000000 | 250 | 400,000% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 813M | 101B | 1% |
| Annual Yield % from dividends | 3.77 | 4.44 | 85% |
| Returns for 1 year | 3.72 | 3.57 | 104% |
| Returns for 3 years | 14.00 | 11.98 | 117% |
| Returns for 5 years | 0.64 | -0.58 | -110% |
| Returns for 10 years | 16.90 | 15.12 | 112% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| FMED | 29.56 | N/A | N/A |
| Fidelity Disruptive Medicine ETF | |||
| MYCF | 25.01 | N/A | N/A |
| State Street® My2026 Corporate Bond ETF | |||
| TPLS | 24.98 | N/A | N/A |
| Thornburg Core Plus Bond ETF | |||
| BGH | 14.14 | -0.06 | -0.42% |
| Barings Global Short Duration High Yield Fund | |||
| EMGF | 69.07 | -2.55 | -3.56% |
| iShares Em Mkts Eq Fac ETF | |||